Racial and ethnic differences in mortality in children awaiting heart transplant in the United States

T P Singh1, K Gauvreau, R Thiagarajan

  • 1Department of Cardiology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA. TP.Singh@cardio.chboston.org

Insights

Minority children awaiting heart transplant (HT) face higher wait-list mortality risks compared to white children. This disparity persists even after accounting for socioeconomic factors, highlighting critical disparities in pediatric HT care.

Area of Science:

  • Pediatric Cardiology
  • Transplant Medicine
  • Health Disparities Research

Background:

  • Racial disparities in pediatric heart transplant (HT) outcomes are established.
  • However, data on racial and ethnic differences in mortality risk among children awaiting HT is limited.

Purpose of the Study:

  • To investigate racial and ethnic disparities in wait-list mortality for children under 18 years old listed for primary heart transplant in the United States.
  • To identify risk factors associated with wait-list mortality across different racial and ethnic groups.

Main Methods:

  • Analysis of a cohort of 3299 children listed for primary heart transplant between 1999 and 2006 in the US.
  • Utilized multivariable Cox proportional hazards models to assess the risk of wait-list mortality.
  • Controlled for clinical variables (age, cardiac diagnosis, support status, renal function, blood group) and socioeconomic factors (insurance, income).

Main Results:

  • Wait-list mortality rates were 14% (White), 19% (Black), 21% (Hispanic), 17% (Asian), and 27% (Other).
  • Black, Hispanic, Asian, and Other children demonstrated significantly higher adjusted hazard ratios for wait-list death compared to White children.
  • These disparities remained significant after adjusting for clinical and socioeconomic variables, though the latter explained a small portion of the increased risk.

Conclusions:

  • Minority children awaiting heart transplant face a significantly elevated risk of mortality compared to their White counterparts.
  • The findings underscore the need for further investigation into the underlying causes of these disparities and for targeted interventions to improve equity in pediatric HT care.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...